Summary

Summary

Contract Unique IdentifierDO1.SLCNTR.709069 
Contract referenceHDSS-2023-00028 
Contract description:ADQUISICION DE MEDICAMENTOS TRIMESTRE-ENERO-MARZO -2023 
Goods 
Contract Start:
07/02/2023 15:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End:
02/03/2023 15:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Legally Binding?
 
Contract StateCompleted 

Contracting Company Identification

Contracting Company Identification


Supplier Company Identification

Supplier Company Identification



Object Info

Object Info

DGCP-01-ComprasMenores 
HDSS-DAF-CM-2023-0005 
ADQUISICION DE MEDICAMENTOS TRIMESTRE-ENERO-MARZO -2023 
ADQUISICION DE MEDICAMENTOS TRIMESTRE-ENERO-MARZO -2023 
FARMACIA 
Pharmaceutical Technology, S.A_EXT 
GoodsDominicana 
350,503.95 Dominican Pesos 

Financial & Delivery Conditions

Financial & Delivery Conditions

Delivery optionsTransporte incluido 
Contract Start Date
07/02/2023 15:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
Contract End Date
02/03/2023 15:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)
 
C PEDRO FCO. BONO #9 CIBAO NORTE DO 

Payment Conditions

Payment Conditions

Payment MethodCheque 
Invoice Payment Deadline60 days 

Contract Comments

Contract Comments


 
 
 1 
DO1.PCCNTR.1512427 ContractData Container
 1.1  
-
    
Total sin descuentosValor del descuentoTotal ITBISTotal Otros ImpuestosSubtotalTotal
350,503.950.000.000.00167,340.00350,503.95
    
ReferenciaCódigo UNSPSCCuenta presupuestariaDescripciónCantidadUnidadPrecio unitario estimadoPrecio unitarioImporte moneda orig. s/ITBIS% Desc.Descuento moneda originalMonto Gravado (Obras)% ITBISITBIS Moneda Original% Otros ImpuestosOtros impuestos moneda originalPrecio total estimadoValor del precio de respuesta
    
17
51121709 - Carvedilol
2.3.4.1.01NIFEDIPINA RETARD 60 MG120UD2948.335,800.000.000.000.003,480.005,800.00
    
18
51131506 - Eritropoyetina
2.3.4.1.01HEPARINA SODICA 25,000 U.I250UD20027568,750.000.000.000.0050,000.0068,750.00
    
37
51121752 - Hidralazina hi(...)
2.3.4.1.01PIPERACILINA/TAZOBATAM INY200UD2001,000200,000.000.000.000.0040,000.00200,000.00
    
53
51191905 - Suplementos vi(...)
2.3.4.1.01ENOXOPARINA 20 MG INY250UD12021052,500.000.000.000.0030,000.0052,500.00
    
79
51101508 - Sulfonamidas a(...)
2.3.4.1.01ENTEROGERMINA VIAL ORAL150UD53609,000.000.000.000.007,950.009,000.00
    
86
51101591 - Vancomicina
2.3.4.1.01NIFEDIPINA RETARD 30 MG90UD21353,150.000.000.000.001,890.003,150.00
    
89
51131604 - Warfarina sódi(...)
2.3.4.1.01ROSUVASTATINA 20 MG120UD3648.335,800.000.000.000.004,320.005,800.00
    
90
51121765 - Metoprolol
2.3.4.1.01BUDESONIDE VIAL NEBULIZAR294UD9918.725,503.950.000.000.0029,700.005,503.95
 
Contract Document Template

Contract Document Template

DescriptionFile Name
Download
Download
Download
Download

Budget Settings

Budget Settings

Investment
General Source
414,015.00 DOP
 DOP
AccountValueAnnual Availability
2.3.4.1.01377,115.00  DOP----View
2.2.9.1.0125,500.00  DOP----View
2.3.9.3.0111,400.00  DOP----View
Payment Calendar
IDDescriptionValueMonthYear
0  ADQUISICION DE MEDICAMENTOS TRIMESTRE-ENERO-MARZO -2023414,015.00  DOPMarzo2023
Certificate of Appropriation
YearCertificate CodeCertificate VersionCertificate ValueCertificate StateCertificate Link
2023CC-0025-20231414,015.00  DOP